ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/17/2023
Back to search
Official data from USPTO
THE EVIDENCE GENERATION COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE EVIDENCE GENERATION COMPANY
ST13
US500000090399437Class
9, 35, 41, 42
Filing
90399437
Registration
7014232
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
05/17/2023
Trademark type
Word
Nice classes
9, 35, 41, 42
Filing date
12/21/2020
Registration date
03/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2021-02-00
First use in commerce
2021-02-00
Drawing code
4
Owner type
16
Owner location
BLUE BELL, PA, US
Examiner
CAYCEDO, CATHERINE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SIGNANT HEALTH GLOBAL LLC
Bracket Global LLC
Representatives
Anna Kurian Shaw Hogan Lovells US LLP
Technical classification
Nice Classes
Class 9Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
DOWNLOADABLE SOFTWARE FOR COMPUTERS AND MOBILE DEVICESTELEMEDICINE SOFTWARE FOR CLINICAL TRIALSREMOTE SITE MONITORING SOFTWAREPATIENT ENGAGEMENT AND COMMUNICATION SOFTWAREPHARMACEUTICAL INDUSTRY CLINICAL TRIAL SOFTWAREDRUG SUPPLY SOFTWAREDATA ANALYTICS AND REPORTING SOFTWARECLINICAL DATA COLLECTION SOFTWARECLINICAL TRIAL PATIENT MONITORING SOFTWAREPATIENT ENGAGEMENT AND COMMUNICATION SOFTWAREPHARMACEUTICAL INDUSTRY CLINICAL TRIAL SOFTWARECLINICAL TRIAL MANAGEMENT SOFTWARECLINICAL TRIAL PATIENT MONITORING SOFTWAREDATA INTEGRATION AND TRANSMISSION SOFTWARECLINICAL TRIAL AUDIO VISUAL SOFTWAREPATIENT CONSENTING SOFTWARE PHARMACEUTICAL INDUSTRY CLINICAL TRIAL SOFTWARERANDOMISATION SOFTWAREDRUG SUPPLY SOFTWAREDATA ANALYTICS AND REPORTING SOFTWARECLINICAL DATA COLLECTION SOFTWARE
Class 35
Business consulting and management services in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trialscustomize ratings reliability activities; providing an internet based database in the field of business information; business consulting services provided to pharmaceutical industry clients involved in phase III and III trials; business consulting and management in the field of clinical trials
Class 41
MEDICAL TRAININGTRAINING OF STAFF IN ADMINISTERING MEDICINE AND TESTINGCOMPLETING PATIENT DOCUMENTATIONUSING TECHNOLOGYIN THE FIELD OF PHARMACEUTICAL STUDIES; PROVISION OF A WEBSITE FEATURING TEMPORARY ONLINE NON-DOWNLOADABLE PUBLICATIONS IN THE NATURE OF REPORTSARTICLES AND PRESENTATIONS IN THE FIELDS OF CLINICAL TRIALS; PROVISION OF TEMPORARY ONLINE NON-DOWNLOADABLE EDUCATIONAL WEBINARS IN THE FIELD OF CLINICAL TRIALS
Class 42
Providing temporary use of non-downloadable software and applications for use in database management and support for use in data collection in connection with clinical trialstelemedicine for clinical trialsremote site monitoring; medical and scientific researchdata collection and data analysis in the nature of conducting clinical research and clinical trials for others in the fields of health caremedical care and pharmaceutical use; provision of an internet based database in the field of medical research for data entry and management; development of customized software for others for use in audit in the nature of electronic approval and audit trail capture in the field of pharmaceutical research and development designed to facilitate complex statistical techniques; programming of computer software for others featuring programming technologies and validation procedures to support subject screeningrandomizationtrial supply managementsite management and electronic patient reported outcomes and registries; providing an internet based database in the field of medical research for data entry and managementproviding an internet based database in the field of medical research for data entry and managementdevelopment of customized software for others for use in auditsoftware for electronic approval and audit trail capture to conduct clinical trials in the field of clinical trials for pharmaceutical research; and development design and development of computer software relating to the field of clinical trials; application service provider (asp) featuring software for use in data collectiondata integrationdata analyticsdata reportingdatabase managementproject management; provision of search platforms in the nature of temporary online non-downloadable software to manage diabetes management data; software as a service (saas) services featuring software for hostingmanagingtransmitting patient data and communicating with patients via video consultsmessaging and surveys; software as a service (saas) services featuring software for enabling patients to select a medication from a list of their frequent medicationsselect a new drug or therapyenter all medication intakeall of which information is added to existing study questionnaires as a way to record concomitant medications; software as a service (saas) services featuring software for the collectioneditingorganizingmodifyingbook markingtransmissionstorage and sharing of clinical outcomes assessments on web basedshort message servicemobile devices; software as a service (saas) services featuring software for conveying to patients information related to a clinical trial using interactive multimedia and for enabling patients to dynamically engagereviewquestion and agree to participate in a clinical trialsoftware as a service (saas) services featuring software for enabling patients to enroll in a clinical study; software as a service (saas) services featuring software for enabling users to viewmanage and report on patient reported data in pharmaceutical industry clinical trials; software as a service (saas) services featuring software for the developmentdesignlocalization and simulation of electronic clinical outcome assessments for pharmaceutical industry clinical trials; consulting services in the design and implementation of computer based information systems related to clinical trial and supply management for businesses; software as a service (saas) services for computers and mobile devices featuring telemedicine software for clinical trialsremote site monitoring softwarepatient engagement and communication softwarepharmaceutical industry clinical trial softwaredrug supply softwaredata analytics and reporting softwareclinical data collection softwareclinical trial patient monitoring softwarepatient engagement and communication softwarepharmaceutical industry clinical trial softwareclinical trial management softwareclinical trial patient monitoring softwaredata integration and transmission softwareclinical trial audio visual softwarepatient consenting software pharmaceutical industry clinical trial softwarerandomisation softwaredrug supply softwaredata analytics and reporting softwareclinical data collection software; providing an internet based computer database in the field of medical and scientific research information from clinical trials; digital image enhancement of videos of rater interviewing for independent evaluation data
Publications
History of USPTO decisions and trademark events.
55 publications found
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/28/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/23/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/11/2023
GNRT
NON-FINAL ACTION E-MAILED
02/11/2023
CNRT
NON-FINAL ACTION WRITTEN
02/11/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/23/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/27/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/15/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2022
GNRT
NON-FINAL ACTION E-MAILED
09/09/2022
CNRT
NON-FINAL ACTION WRITTEN
09/09/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/02/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/19/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/06/2022
ALIE
ASSIGNED TO LIE
06/30/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/23/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
06/10/2022
IUAA
USE AMENDMENT ACCEPTED
06/09/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/06/2022
IUAF
USE AMENDMENT FILED
05/06/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/05/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/10/2022
GNFR
FINAL REFUSAL E-MAILED
02/10/2022
CNFR
FINAL REFUSAL WRITTEN
02/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2021
GNRT
NON-FINAL ACTION E-MAILED
06/29/2021
CNRT
NON-FINAL ACTION WRITTEN
06/29/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/16/2021
DOCK
ASSIGNED TO EXAMINER
06/15/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2021
NWAP
NEW APPLICATION ENTERED
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens THE EVIDENCE GENERATION COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.